The European Haemophilia Consortium marked World Haemophilia Day by highlighting real achievement and real recommendations.

The organisation dedicated its event in Strasbourg to the latest consensus recommendations, which were developed during the 2016 Wild Bad Kreuth IV initiative. Through presentations and discussions, participants had the chance to find out more about these important recommendations and what actions will be taken in order to get them implemented in European countries.

The EHC also took the opportunity to officially unveil their PARTNERS project, which is aimed at increasing access to replacement therapies in European countries that provide little or no such treatment to their haemophilia patients.

A special thank you to the  European Directorate for the Quality of Medicines and Healthcare (EDQM), an agency of the Council of Europe, for their support and hosting of EHCs’ event.

For all details, quotes and highlights, please refer to:

EHC WHD Event 2017 Press Release